Cardiocentro Ticino
Clinical trials sponsored by Cardiocentro Ticino, explained in plain language.
-
Heart stent patients: could a tailored blood thinner dose prevent clots and bleeding?
Disease control Recruiting nowThis study looks for the best type and dose of blood thinner (P2Y12 inhibitor) for people who have had a heart stent placed. After an initial period on two blood thinners, patients switch to one. The goal is to find a dose that keeps blood clotting at a safe level—not too high (w…
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New blood thinner could make heart bypass safer during surgery
Disease control Recruiting nowThis study is testing whether giving the blood thinner cangrelor through a vein during minimally invasive heart bypass surgery is safe and practical. The goal is to prevent dangerous blood clots while the patient is on the operating table. Researchers will compare 30 patients rec…
Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
AI eye on the heart: new tool could catch silent attacks
Diagnosis Recruiting nowThis study tests whether an artificial intelligence (AI) tool can help doctors identify heart attacks that standard ECG tests miss. About 500 adults with chest pain but no clear signs of a heart attack on their initial ECG will be randomly assigned to get either AI-assisted or st…
Phase: NA • Sponsor: Cardiocentro Ticino • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New heart ablation tool could cut radiation and costs
Symptom relief Recruiting nowThis study compares a new second-generation catheter (FARAWAVE Nav) used without a pre-procedure CT scan to the standard approach with a CT scan for treating atrial fibrillation. The goal is to see if the new method reduces radiation exposure and procedure time. 58 adults with at…
Phase: NA • Sponsor: Cardiocentro Ticino • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC